Key Takeaway: REDWOOD CITY, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the following investor conferences in March.
42nd Annual Cowen Health Care Conference on Wednesday, March 9 at 10:
Price reaction · baseline $11.56 (2022-03-03 close) · hit after-hours · clean, no other CHRS news in the window
day 0 close · peak
+2.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis
Full Press Release Details
REDWOOD CITY, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the following investor conferences in March.
42nd Annual Cowen Health Care Conference on Wednesday, March 9 at 10:30 a.m. ET
Barclays Global Healthcare Conference on Tuesday, March 15 at 2:35 p.m. ET
Audio webcasts of these presentations will be available on the investors’ page of the Coherus website at http://investors.coherus.com. Please access the website prior to the start of the presentation to ensure a timely connection to the webcast. Each webcast will be archived on the Coherus website for 30 days.